Virtus Investment Advisers, Inc. has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $286 Million distributed in 439 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ofs Credit Company, Inc. with a value of $2.18M, Oracle Corp with a value of $2.19M, Vistra Corp. with a value of $2.12M, Royal Caribbean Cruises LTD with a value of $2.05M, and Incyte Corp with a value of $2.03M.
Examining the 13F form we can see an decrease of $2.87M in the current position value, from $289M to 286M .
Virtus Investment Advisers, Inc. is based out at Hartford, CT
Below you can find more details about Virtus Investment Advisers, Inc. portfolio as well as his latest detailed transactions.
Portfolio value
$286 Million
Financial Services: $113 Million
Healthcare: $48.2 Million
Technology: $33.4 Million
Industrials: $28.7 Million
Consumer Cyclical: $13.3 Million
Communication Services: $12.1 Million
Real Estate: $10.6 Million
Consumer Defensive: $8.44 Million
Other: $17.1 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 37.6%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 63.23%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 66.92%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 44.81%
Morgan Stanley Direct Lendin
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.57%
-
$0
0.0% of portfolio
-
Q2 2025
Added 41.55%
-
$0
0.0% of portfolio
-
Q2 2025
New
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.11%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 4.23%
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 53.3%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 40.4%
Mind Medicine Mindmed Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 44.92%
-
$0
0.0% of portfolio
-
Q2 2025
Added 33.92%
Praxis Precision Medicines I
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 9.84%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 39.31%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 33.03%
Dianthus Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 30.22%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 35.18%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 2.27%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.66%
-
$0
0.0% of portfolio
-
Q2 2025
Added 47.73%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 30.2%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 27.65%
-
$0
0.0% of portfolio
-
Q2 2025
Added 15.26%
-
$0
0.0% of portfolio
-
Q2 2025
Added 9.57%
Structure Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 18.25%
Oaktree Specialty Lending CO
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 9.34%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 37.3%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 31.67%
-
$0
0.0% of portfolio
-
Q2 2025
Added 33.38%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 22.61%
Cartesian Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 12.54%
-
$0
0.0% of portfolio
-
Q2 2025
New
Nuveen Churchill Direct Lend
-
$0
0.0% of portfolio
-
Q2 2025
Added 12.18%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 12.41%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 37.32%
-
$0
0.0% of portfolio
-
Q2 2025
Added 18.33%